In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic Target

SIMPLE SUMMARY: Despite novel targeted treatment options, small cell lung cancer (SCLC) still has a bad prognosis. However, as a relevant number of SCLC patients show a high expression of somatostatin receptors (SSTRs), SSTR-targeted radionuclide therapy (PRRT) may be a treatment option. Therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales: Şen, Feyza, Sheikh, Gabriel T., von Hinten, Johannes, Schindele, Andreas, Kircher, Malte, Dierks, Alexander, Pfob, Christian H., Serfling, Sebastian E., Buck, Andreas K., Pelzer, Theo, Higuchi, Takahiro, Weich, Alexander, Bundschuh, Ralph A., Werner, Rudolf A., Lapa, Constantin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377032/
https://www.ncbi.nlm.nih.gov/pubmed/37509258
http://dx.doi.org/10.3390/cancers15143595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377032/
https://www.ncbi.nlm.nih.gov/pubmed/37509258
http://dx.doi.org/10.3390/cancers15143595

Ejemplares similares